Skip to main content
. 2021 Jan 15;12(1):270–280. doi: 10.1080/21505594.2020.1870080

Table 1.

Baseline characteristics of the CHC patients

  Total, n = 842 SVR (+), n = 427 SVR (-), n = 92 p Values
Male, n (%) # 449 (53.3) 248 (58.1) 47 (51.1) 0.231
Age (year) 55.30±12.50 53.83±11.48 56±10.92 0.086
BMI (kg/m2) 24.85±3.875 24.84±3.572 25.54±4.112 0.126
HCV RNA (Log10 IU/ml) 4.191±7.338 4.628±8.505 6.220±6.889 <0.001
HCV genotype, n (%)#        
Genotype 1 466 (55.3) 204 (47.8) 74 (80.4) <0.001
Genotype 2 314 (37.3) 196 (46) 14 (15.2) <0.001
Others 62 (7.3) 27 (6.3) 4 (4.3) 0.368
Uric acid (mg/dL) 5.91±1.55 5.97±1.55 5.81±1.50 0.404
HOMA-IR 3.18±5.14 2.91±4.41 4.34±5.41 0.028
C-peptide (ng/mL) 2.56±1.92 2.46±1.84 3.35±3.06 0.016
Liver cirrhosis, n (%) # 181 (21.5) 77 (18.1) 36 (39.1) <0.001
ALT (U/L) 92.21±98.34 100.8±103.8 85.31±78.02 0.188
Platelets count (103/µL) 178.7±66.27 180.9±58.19 154.1±57.68 <0.001
TC (mg/dL) 173.7±34.32 174.3±32.21 173.2±30.24 0.87
TGs (mg/dL) 109.0±59.73 110.4±60.86 100.2±57.90 0.433
HDL-C (mg/dL) 47.71±13.77 47.82±13.89 47.83±14.53 0.993
HS-CRP (mg/dL) 1.93±3.90 1.71±3.56 1.75±3.14 0.913
eNAMPT (ng/mL) 5.93±4.17 5.95±4.06 5.50±3.24 0.382
eGFR (ml/min) 100.5±32.5 100.6±30.6 99.5±33.9 0.779
rs12979860, CC genotype, n (%) # 726 (86.2) 380 (89.41) 65 (70.7) <0.001
rs61330082, TT genotype, n (%) # 168 (19.9) 96 (22.5) 21 (23.0) 0.477
rs7789066, AA genotype, n (%) # 841 (99.9) 426 (99.8) 92 (100) 0.824
rs10953502, TT genotype, n (%) # 692 (82.2) 349 (80.5) 75 (81.5) 0.889
rs2302559, CC genotype, n (%) # 638 (75.8) 330 (77.3) 64 (70.0) 0.314
rs10487818, AA genotype, n (%) # 842 (100) 427 (100) 92 (100) NA
rs2058539, AA genotype, n (%) # 653 (77.6) 336 (78.7) 71 (77.4) 0.654
rs1319501, TT genotype, n (%) # 842 (100) 427 (100) 92 (100) NA
rs9770242, AA genotype, n (%) # 842 (100) 427 (100) 92 (100) NA

CHC: chronic hepatitis C virus infection; #: chi-squared test; SVR: sustained virological response; BMI: body mass index; Log: logarithmic; HOMA-IR: homeostasis model assessment-estimated insulin resistance; ALT: alanine aminotransferase; TC: total cholesterol; TGs: triglycerides; HDL-C: high-density lipoprotein-cholesterol; HS-CRP: high sensitive C-reactive protein; eGFR: estimated glomerular filtration rate; eNAMPT: extracellular nicotinamide phosphoribosyltransferase; NA: not assessable due to no polymorphism.